Jocelyn Marie Harrington, RPAC

Jocelyn Harrington practices at Rochester Colon and Rectal Surgeons in Rochester, New York.

Jocelyn Harrington's NPI, 1427381441, was assigned on September 9, 2009. Jocelyn Harrington holds New York license 011566.

Jocelyn Harrington's primary practice is Rochester Colon and Rectal Surgeons, at 1255 Portland Ave, Rochester, NY 14621 in Monroe County. The practice phone is (585) 222-6566.

Jocelyn Harrington's primary practice is Rochester Colon and Rectal Surgeons in Rochester, New York. The medical group on file is Allergy, Asthma, Immunology of Rochester. Dmand AI also links Jocelyn Harrington to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jocelyn Harrington practices, 2 sites in all. Vendor and product names are available with a free account.

Surgical is Jocelyn Harrington's primary specialty in the NPI Registry, under taxonomy code 363AS0400X. Jocelyn Harrington is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Jocelyn Harrington is licensed in New York.

Dmand AI lists hemorrhoids and itchy rashes among the conditions Jocelyn Harrington treats.

CMS data shows 85 Medicare services from Jocelyn Harrington across 4 procedure codes in 2024, for 74 Medicare patients. Medicare paid $4,539 for them. Every service was in an office.

CMS counts 74 Medicare patients who saw Jocelyn Harrington in 2024. The largest group is 65 to 74, with 34 patients. 73% of them have high cholesterol, and 64% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jocelyn Harrington's median patient age at 47, with 67% women.

In 2024, Jocelyn Harrington wrote 240 Medicare Part D claims for 66 patients. 63% of them were for generic drugs. CMS names the drug for 148 of them, across 8 drugs with 11 or more claims each, at $655,039 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Jocelyn Harrington for performance year 2024, reported as part of a group. Jocelyn Harrington accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 52 general payments to Jocelyn Harrington from 15 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $223.